Epidemiological Study on Community Acquired Pneumonia

Recruiting Observational Study
Community Acquired Pneumonia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
20,000 (estimated)
Sponsor
Capnetz Stiftung · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The main objective of this study is to investigate prevalence and risk factors for community-acquired pneumonia (CAP) and its interaction with comorbidities in an unselected group of adult patients receiving outpatient and inpatient care. In addition, information on HIV as a risk factor for CAP and on CAP in immunocompromised patients is collected.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * age ≥ 18 * infiltrate on chest X-ray * further Inclusion criteria (at least one must apply): cough or purulent sputum or pathologic lung auscultation (crackles) or fever Exclusion Criteria: * Hospitalization lasting longer than 48 hours prior to the diagnosis of the current …
Contacts

Frank Eberhardt

+49-511-532-5927

office@capnetz.de

CONTACT

Waldemar Kröner

+49-511-532-4447

office@capnetz.de

CONTACT